Integrative Analysis of MAPK14 as a Potential Biomarker for Cardioembolic Stroke

Figure 6

The identification of MAPK14 as a biomarker for CS. (a). Final overlap of WGCNA hub genes and DEG hub genes. (b). Violin plots representing expression of MAPK14 in 3 h, 5 h, and 24 h following CS were all significantly increased compared to normal individuals in dataset GSE58294. (c). Receiver operating characteristic (ROC) curves for blood MAPK14 in 3 h, 5 h, and 24 h following CS in dataset GSE58294. MAPK14: mitogen-activated protein kinase 14; CS: cardioembolic stroke; WGCNA: weighted gene coexpression network analysis; DEGs: differentially expressed genes.

(a)

(b)

(c)